Abstract
C-reactive protein (CRP) can be structurally modified by heat, acid, or urea-chelation to express a neoantigen designated by us as neo-CRP. This antigen is also expressed on the in vitro primary protein translation products of both human and rabbit CRP. Unmodified CRP and CRP complexed with pneumococcal C-poly-saccharide (CPS) do not express neo-CRP. Forms of CRP expressing neo-CRP but not native CRP antigenicity (even in the presence of CPS) consistently and in a dosedependent manner potentiated the respiratory burst response of human polymorphonuclear leukocytes and peripheral blood monocytes to heat-modified IgG. Forms of CRP expressing neo-CRP antigenicity also induced reactions of aggregation and secretion from isolated platelets and potentiated platelet activation stimulated by ADP in platelet-rich-plasma, while native CRP alone or complexed with CPS again did not. Unlike CRP-CPS complexes, forms of CRP expressing neo-CRP were not able to activate the complement system. These data emphasize the biologic potential inherent in this humoral acute-phase reactant, particularly in the activation of the formed elements of the blood important in the inflammatory response. Since these cell-activating properties are preferentially observed when CRP is structurally modified to express the neo-CRP antigen, such a molecular conversion may be central to the structure-function relationships of CRP at local sites of inflammation and tissue injury.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Kushner, I., M. L. Broder, andD. Karp. 1978. Control of the acute phase response. Serum C-reactive protein kinetics after acute myocardial infarction.J. Clin. Invest. 61:235–242.
McAdam, K. P., R. J. Elin, J. D. Sipe, andS. M. Wolff. 1978. Changes in human serum amyloid A and C-reactive protein after etiocholanolone-induced inflammation.J. Clin. Invest. 61:390–394.
Gewurz, H., C. M. Mold, J. Siegel, andB. A. Fiedel. 1982. C-reactive protein and the acute phase response.Adv. Intern. Med. 27:345–372.
Pepys, M. B., andM. L. Baltz. 1983. Acute phase proteins with specific reference to C-reactive protein and related proteins (pentraxins) and serum amyloid A protein.Adv. Immunol. 34:141–212.
Osmand, A. P., B. Friedenson, H. Gewurz, R. H. Painter, T. Hofmann, andE. Shelton. 1977. Characterization of C-reactive protein and the complement subcomponent C1t as homologous proteins displaying cyclic pentameric symmetry (pentraxins).Proc. Natl. Acad. Sci U.S.A. 74:739–743.
Gotschlich, E. C., andG. M. Edelman. 1965. C-reactive protein: A molecule composed of subunits.Proc. Natl. Acad. Sci U.S.A. 54:558–566.
Lei, K.-J., T. Liu, G. Zon, E. Soravia, T.-Y. Liu, andN. D. Goldman. 1985. Genomic DNA sequence for human C-reactive protein.J. Biol. Chem. 260:13377–13383.
Whitehead, A. S., G. A. P. Bruns, A. F. Markham, H. R. Colten, andD. E. Woods. 1983. Isolation of human C-reactive protein complementary DNA and localizing of the gene to chromosome 1.Science 221:69–71.
Woo, P., J. R. Korenberg, andA. S. Whitehead. 1985. Characterization of genomic and complementary DNA sequences of human C-reactive protein and comparison with the complementary DNA sequence of serum amyloid P component.J. Biol. Chem. 260:13384–13388.
Gotschlich, E. C., andG. M. Edelman. 1967. Binding properties and specificity of C-reactive protein.Proc. Natl. Acad. Sci. U.S.A. 57:706–712.
Young, N. M., andR. E. Williams. 1978. Comparison of the secondary structures and binding sites of C-reactive protein and the phosphorylcholine-binding murine myeloma proteins.J. Immunol. 121:1893–1898.
Volanakis, J. E., andJ. F. Kearney. 1981. Cross-reactivity between C-reactive protein and idiotypic determinants on a phosphocholine-binding murine myeloma protein.J. Exp. Med. 153:1604–1614.
Potempa, L. A., B. A. Maldonado, P. Laurent, E. Zemel, andH. Gewurz. 1983. Antigenic, electrophoretic and binding alterations of human C-reactive protein modified selectively in the absence of calcium.Mol. Immunol. 20:1165–1175.
Volanakis, J. E., andM. H. Kaplan. 1971. Specificity of C-reactive protein for choline phosphate residues of pneumococcal C-polysaccharide.Proc. Soc. Exp. Biol. Med. 136:612–614.
DiCamelli, R., L. A. Potempa, J. Siegel, L. Suyehira, K. Petras, andH. Gewurz. 1980. Binding reactivity of C-reactive protein for poly cations.J. Immunol. 125:1933–1938.
Potempa, L. A., J. N. Siegel, andH. Gewurz. 1982. C-reactive protein (CRP) reactivity with polycations. II. Modulatory effects of calcium and phosphocholine.J. Immunol. 127:1509–1514.
Robey, F. A., K. D. Jones, T. Tanaka, andT.-Y. Liu. 1984. Binding of C-reactive protein to chromatin and nucleosome core particles.J. Biol. Chem. 259:7311–7316.
Shepard, E. G., P. D. VanHelden, M. Strauss, L. Bohm, andF. C. DeBeer. 1986. Functional effects of CRP binding to nuclei.Immunology 58:489–494.
Zeller, J. M., A. L. Landay, T. F. Lint, andH. Gewurz. 1986. Aggregated C-reactive protein binds to and potentiates Fc receptor-mediated chemiluminescence in human polymorphonuclear leukocytes.J. Lab. Clin. Med. 108:567–576.
Shephard, E. G., R. Anderson, A. F. Strachan, S. H. Kuhn, andF. C. Debeer. 1986. CRP and neutrophils: Functional effects and complex uptake.Clin. Exp. Immunol. 63:718–727.
Zeller, J. M., A. L. Landay, T. F. Lint, andH. Gewurz. 1986. Enhancement of human peripheral blood monocyte respiratory burst activity of aggregated C-reactive protein.J. Leukocyte Biol. 40:769–783.
Potempa, L. A., H. Gewurz, J. E. Harris, andD. P. Braun. 1986. Stimulatory effects of the C-reactive protein subunit on monocyte function including release of IL-1.Protides Biol. Fluids. 34:287–290.
Fiedel, B. A., R. M. Simpson, andH. Gewurz. 1982. Activation of platelets by modified C-reactive protein.Immunology 45:439–447.
Fiedel, B. A. 1985. Platelet agonist synergism by the acute phase reactant C-reactive protein.Blood 65:264–269.
James, K., B. Hansen, andH. Gewurz. 1981. Binding of C-reactive protein to human mononuclear cells. I. Requirement for a binding specificity.J. Immunol. 127:2539–2544.
James, K., L. Baum, M. Vetter, andH. Gewurz. 1982. Interactions of C-reactive protein with lymphoid cells.Ann. N.Y. Acad. Sci. 389:274–285.
Kaplan, M. H., andJ. E. Volanakis. 1974. Interaction of C-reactive protein complexes with the complement system. I. Consumption of human complement-associated with the reaction of C-reactive protein with pneumococcal C-polysaccharide and with choline phosphatides, lecithin and sphingomyelin.J. Immunol. 112:2135–2147.
Claus, D. R., J. Siegel, K. Petras, A. P. Osmand, andH. Gewurz. 1977. Interactions of C-reactive protein with the first component of human complement.J. Immunol. 119:187–192.
Volanakis, J. 1982. Complement-induced solubilization of C-reactive protein-pneumococcal C-polysaccharide precipitates: Evidence for covalent binding of complement proteins to C-reactive protein and to pneumococcal C-polysaccharide.J. Immunol. 128:2745–2750.
Volanakis, J. E., andA. J. Narrates. 1983. Binding of human C4 to C-reactive protein-pneumococcal C-polysaccharide complexes during activation of the classical complement pathway.Mol Immunol. 20:1201–1207.
Volanakis, J. E. 1982. Complement activation by C-reactive protein complexes.Ann. N.Y. Acad. Sci. 389:235–250.
Mold, C., T. W. DuClos, S. Nakayama, K. M. Edwards, andH. Gewurz. 1982. C-reactive protein reactivity with complement and effects on phagocytosis.Ann. N.Y. Acad. Sci. 389:251–262.
Nakayama, S., C. Mold, H. Gewurz, andT. W. DuClos. 1982. Opsonic properties of C-reactive protein in vivo.J. Immunol. 128:2435–2438.
Edwards, K. M., H. Gewurz, T. F. Lint, andC. Mold. 1982. A role for C-reactive protein in the complement-mediated Stimulation of human neutrophils by type 27Streptococcus pneumonia. J. Immunol. 128:2493–2496.
Kilpatrick, J. M., andJ. E. Volanakis. 1985. Opsonic properties of C-reactive protein. Stimulation by phorbol myristate acetate enables human neutrophils to phagocytize C-reactive protein-coated cells.J. Immunol. 134:3364–3370.
Muller, H., andJ. Fehr. 1986. Binding of C-reactive protein to human polymorphonuclear leukocytes: Evidence for association of binding sites with Fc receptors.J. Immunol. 136:2202–2207.
Potempa, L. A., J. N. Siegel, B. A. Fiedel, R. T. Potempa, andH. Gewurz. 1987. Expression, detection and assay of a neoantigen (neo-CRP) associated with a free, human Creactive protein subunit.Mol. Immunol. 24:531–541.
Mortensen, R. F., A. P. Osmand, T. F. Lint, andH. Gewurz. 1976. Interaction of C-reactive protein with lymphocytes and monocytes: Complement-dependent adherence and phagocytosis.J. Immunol. 117:774–781.
Fairbanks, T. R. 1984. Influence of acid pH on structure, binding and biological reactivity of C-reactive protein. PhD dissertation. Rush University, Chicago, Illinois, 60612.
James, K., B. Hansen, andH. Gewurz. 1981. Binding of C-reactive protein to human mononuclear cells. II. Interation with a subset of cells bearing the Fc receptor.J. Immunol. 127:2545–2552.
Lowry, O. H., H. J. Rosebrough, A. L. Farr, andR. J. Randall. 1951. Protein measurement with the Folin phenol reagent.J. Biol. Chem. 193:265–275.
Liu, T.-Y., and E. C.Gotschlich. The chemical composition of pneumococcal C-polysaccharide,J. Biol. Chem. 238:1928–1934.
Ross, G. D., andR. J. Winchester. 1980. Methods for enumerating lymphocyte populations.In Manual of Clinical Immunology. N. R. Rose and H. Friedman, editors. American Society of Microbiology, Washington, D.C. 213.
Gewurz, H., andL. A. Suyehira. 1980. Complement.In Manual of Clinical Immunology. N. R. Rose and H. Friedman, editors. American Society for Microbiology, Washington, D.C. 163–174
Vetter, M. L., H. Gewurz, B. Hansen, K. James, andL. L. Baum. 1983. Effects of Creactive protein on human lymphocyte responsiveness.J. Immunol. 130:2121–2126.
Zeller, J. M., J. Caliendo, andH. Gewurz. 1986. Modulation of C-reactive protein and IgG binding to human monocytes by surface immobilized ligands.Fed. Proc. 45:262a.
Fiedel, B. A., J. N. Siegel, H. Gewurz, R. M. Simpson, andJ. M. Izzi. 1982. Comparison of the enzymatic sensitivities of the platelet receptor for human C-reactive protein and its functional relationship to the platelet IgG Fc receptor.Clin. Exp. Immunol. 50:215–222.
Chu, E. B., L. A. Potempa, J. E. Harris, H. Gewurz, andD. P. Braun. 1987. Modulation of monocyte cytotoxicity with urea-chelated and acid-modified C-reactive protein (CRP).Proc. Am. Cancer Soc. 28:344a.
Rees, R., H. Gewurz, J. N. Siegel, andL. A. Potempa. 1986. An immunochemical study of the in vivo expression of a C-reactive protein neoantigen (neo-CRP) in the rabbit.Fed. Proc. 45:263a.
Bray, R. A., N. L. Samberg, A. L. Landay, H. Gewurz, andL. A. Potempa. 1987. Identification of a novel antigenic specificity present on the surface of human natural killer cells and B-lymphocytes.Clin. Immunol. Newsl. 8:137–140.
Author information
Authors and Affiliations
Additional information
Supported in part by Biomedical Research Support Grant 97881 (Rush Presbyterian St. Luke's Medical Center), R23AI23030 (National Institute of Allergy and Infectious Diseases) and HL-23457 (National Heart, Lung & Blood Institute). B.A.F. was the recipient of an NIH Research Career Development Award HL-00614. H.G. holds the Thomas G. Coogan, Sr. Chair in Immunology established by Marjorie Lindheimer Everett.
Rights and permissions
About this article
Cite this article
Potempa, L.A., Zeller, J.M., Fiedel, B.A. et al. Stimulation of human neutrophils, monocytes, and platelets by modified C-reactive protein (CRP) expressing a neoantigenic specificity. Inflammation 12, 391–405 (1988). https://doi.org/10.1007/BF00915774
Issue Date:
DOI: https://doi.org/10.1007/BF00915774